223 related articles for article (PubMed ID: 26202809)
1. Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women.
Boroń D; Kotrych D; Bartkowiak-Wieczorek J; Uzar I; Bogacz A; Kamiński A
Int Immunopharmacol; 2015 Sep; 28(1):477-86. PubMed ID: 26202809
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
Seremak-Mrozikiewicz A; Tatuśko J; Drews K; Barlik M; Krajewski P; Spaczyński M; Mrozikiewicz PM
Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
[TBL] [Abstract][Full Text] [Related]
3. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
4. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
5. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
[TBL] [Abstract][Full Text] [Related]
6. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
8. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
Boroń D; Kamiński A; Kotrych D; Bogacz A; Uzar I; Mrozikiewicz PM; Czerny B
Osteoporos Int; 2015 Mar; 26(3):1045-52. PubMed ID: 25407264
[TBL] [Abstract][Full Text] [Related]
10. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
11. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
12. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
13. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
14. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang F; He C; Chen G; Li F; Gao H
Med Oncol; 2013 Mar; 30(1):389. PubMed ID: 23335067
[TBL] [Abstract][Full Text] [Related]
15. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
Peng Y; Sheng X; Xue F; Qian Y
Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of collagen 1A1 (COL1A1) gene and their relation to bone mineral density in postmenopausal women.
Majchrzycki M; Bartkowiak-Wieczorek J; Wolski H; Drews K; Bogacz A; Czerny B; Zagrodnik-Ułan E; Seremak-Mrozikiewicz A
Ginekol Pol; 2015 Dec; 86(12):907-14. PubMed ID: 26995940
[TBL] [Abstract][Full Text] [Related]
18. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women.
Boroń D; Agnieszka SM; Daniel K; Anna B; Adam K
Eur J Med Res; 2014 Dec; 19(1):69. PubMed ID: 25510225
[TBL] [Abstract][Full Text] [Related]
20. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women.
Song JF; Jing ZZ; Hu W; Su YX
Genet Mol Res; 2013 Sep; 12(3):3279-85. PubMed ID: 24065669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
